Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02642159
Brief Title: Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)

First Submitted : December 24, 2015
First Submitted that Met QC Criteria : December 24, 2015
First Posted : December 30, 2015 (Estimate)

Results First Submitted : March 20, 2018
Results First Submitted that Met QC Criteria : April 30, 2018
Results First Posted : May 1, 2018

Last Update Submitted that Met QC Criteria : April 30, 2018
Last Update Posted : May 1, 2018